Association Between the Polymorphism of Angiotensin-Converting Enzyme Gene and Interleukin-1 Beta Gene and the Response to Erythropoietin Therapy in Dialysis Patients with Anemia

1 Winearls CG, Oliver DO, Pippard MJ, Reid C, Downing MR, Cotes PM. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet. 1986; 2(8517):1175–1178. WinearlsCG OliverDO PippardMJ ReidC DowningMR CotesPM Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis Lancet 1986 2 8517 1175 1178 Search in Google Scholar

2 Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med. 1987 Jan 8;316(2):73–78. EschbachJW EgrieJC DowningMR BrowneJK AdamsonJW Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial N Engl J Med 1987 Jan 8 316 2 73 78 Search in Google Scholar

3 Zins B, Drueke T, Zingraff J, Bererhi L, Kreis H, Naret C, et al. Erythropoietin treatment in anaemic patients on haemodialysis. Lancet. 1986;2(8519):1329. ZinsB DruekeT ZingraffJ BererhiL KreisH NaretC Erythropoietin treatment in anaemic patients on haemodialysis Lancet 1986 2 8519 1329 Search in Google Scholar

4 Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and detin. N Engl J Med. 1998; 339(9):584–590. BesarabA BoltonWK BrowneJK EgrieJC NissensonAR OkamotoDM The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and detin N Engl J Med 1998 339 9 584 590 Search in Google Scholar

5 Locatelli F, Pisoni RL, Combe C, Bommer J, Andreucci VE, Piera L, et al. Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2004; 19(1):121–132. LocatelliF PisoniRL CombeC BommerJ AndreucciVE PieraL Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Nephrol Dial Transplant 2004 19 1 121 132 Search in Google Scholar

6 Wyatt CM, Drueke TB. Higher hemoglobin levels and quality of life in patients with advanced chronic kidney disease: no longer a moving target? Kidney Int. 2016 May;89(5):971–973. WyattCM DruekeTB Higher hemoglobin levels and quality of life in patients with advanced chronic kidney disease: no longer a moving target? Kidney Int. 2016 May 89 5 971 973 Search in Google Scholar

7 Okazaki M, Komatsu M, Kawaguchi H, Tsuchiya K, Nitta K. Erythropoietin resistance index and the all-cause mortality of chronic hemodialysis patients. Blood Purif. 2014;37(2):106–112. OkazakiM KomatsuM KawaguchiH TsuchiyaK NittaK Erythropoietin resistance index and the all-cause mortality of chronic hemodialysis patients Blood Purif 2014 37 2 106 112 Search in Google Scholar

8 KDIGO clinical practice guideline for anemia in chronic kidney disease. Chapter 3. Use of ESAs and other agents to treat anemia in CKD. Kidney Int Suppl. 2012; 2:299–310. KDIGO clinical practice guideline for anemia in chronic kidney disease. Chapter 3. Use of ESAs and other agents to treat anemia in CKD Kidney Int Suppl 2012 2 299 310 Search in Google Scholar

9 USRDS. 2013 Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States, national institutes of health, and national institute of diabetes and digestive and kidney diseases. MD: Bethesda; 2013. USRDS 2013 Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States, national institutes of health, and national institute of diabetes and digestive and kidney diseases MD Bethesda 2013 Search in Google Scholar

10 Wong HS, Chang CM, Kao CC, Hsu YW, Liu X, Chang WC, Wu MS, Chang WC. V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients. J Biomed Sci. 2017 Jul 11;24(1):43. WongHS ChangCM KaoCC HsuYW LiuX ChangWC WuMS ChangWC V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients J Biomed Sci 2017 Jul 11 24 1 43 Search in Google Scholar

11 Priyadarshi A, Shapiro JI. Erythropoietin resistance in the treatment of the anemia of chronic renal failure. Semin Dial 2006;19:273–278. PriyadarshiA ShapiroJI Erythropoietin resistance in the treatment of the anemia of chronic renal failure Semin Dial 2006 19 273 278 Search in Google Scholar

12 Sharples EJ, Varagunam M, Sinnott PJ, McCloskey DJ, Raftery MJ, Yaqoob MM. The effect of proinflammatory cytokine gene and angiotensin-converting enzyme polymorphism on erythropoietin requirements in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 2006; 26:64–68. SharplesEJ VaragunamM SinnottPJ McCloskeyDJ RafteryMJ YaqoobMM The effect of proinflammatory cytokine gene and angiotensin-converting enzyme polymorphism on erythropoietin requirements in patients on continuous ambulatory peritoneal dialysis Perit Dial Int 2006 26 64 68 Search in Google Scholar

13 Nand N, Deshmukh AR, Joshi S, Sachdeva MP, Sakthivel. Role of ACE and IL-1β Gene Polymorphism in Erythropoeitin Hyporesponsive Patients with Chronic Kidney Disease with Anemia. J Assoc Physicians India. 2017 Feb;65(2):32–36. NandN DeshmukhAR JoshiS SachdevaMP Sakthivel Role of ACE and IL-1β Gene Polymorphism in Erythropoeitin Hyporesponsive Patients with Chronic Kidney Disease with Anemia J Assoc Physicians India 2017 Feb 65 2 32 36 Search in Google Scholar

14 Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343–1346. RigatB HubertC Alhenc-GelasF CambienF CorvolP SoubrierF An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels J Clin Invest 1990 86 1343 1346 Search in Google Scholar

15 Mrug M, Stopka T, Julian BA, Prchal JF, Prchal JT. Angiotensin II stimulates proliferation of normal early erythroid progenitors. J Clin Invest 1997;100: 2310–2314. MrugM StopkaT JulianBA PrchalJF PrchalJT Angiotensin II stimulates proliferation of normal early erythroid progenitors J Clin Invest 1997 100 2310 2314 Search in Google Scholar

16 Kim YC, Mungunsukh O, Day RM. Erythropoietin Regulation by Angiotensin II. Vitam Horm. 2017; 105:57–77. KimYC MungunsukhO DayRM Erythropoietin Regulation by Angiotensin II Vitam Horm 2017 105 57 77 Search in Google Scholar

17 Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87: 2095–2147. DinarelloCA Biologic basis for interleukin-1 in disease Blood 1996 87 2095 2147 Search in Google Scholar

18 Jelkmann W. Proinflammatory cytokines lowering erythropoietin production. J Interferon Cytokine Res 1998; 18:555–559. JelkmannW Proinflammatory cytokines lowering erythropoietin production J Interferon Cytokine Res 1998 18 555 559 Search in Google Scholar

19 Jeong KH, Lee TW, Ihm CG, Lee SH, Moon JY. Polymorphism in two genes, IL-1B and ACE, are associated with erythropoietin resistance in Korean patients on maintenance hemodialysis. Exp Mol Med. 2008 Apr 30;40(2):161–166 JeongKH LeeTW IhmCG LeeSH MoonJY Polymorphism in two genes, IL-1B and ACE, are associated with erythropoietin resistance in Korean patients on maintenance hemodialysis Exp Mol Med 2008 Apr 30 40 2 161 166 Search in Google Scholar

20 Berns JS. Interpretation of the Kidney Disease: Improving Global Outcomes guidelines for iron therapy: commentary and emerging evidence. Clin Kidney J. 2017 Dec;10(Suppl 1):i3–i8. BernsJS Interpretation of the Kidney Disease: Improving Global Outcomes guidelines for iron therapy: commentary and emerging evidence Clin Kidney J 2017 Dec 10 Suppl 1 i3 i8 Search in Google Scholar

21 KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD). Kidney International Supplements 2017; 7: 1–59. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Kidney International Supplements 2017 7 1 59 Search in Google Scholar

22 Varagunam M, McCloskey DJ, Sinnott PJ, Raftery MJ, Yaqoob MM. Angiotensin-converting enzyme gene polymorphism and erythropoietin requirement. Perit Dial Int 2003; 23:111–115. VaragunamM McCloskeyDJ SinnottPJ RafteryMJ YaqoobMM Angiotensin-converting enzyme gene polymorphism and erythropoietin requirement Perit Dial Int 2003 23 111 115 Search in Google Scholar

23 Santos EJF, Hortegal EV, Serra HO, Lages JS, Salgado-Filho N, Dos Santos AM. Epoetin alfa resistance in hemodialysis patients with chronic kidney disease: a longitudinal study. Braz J Med Biol Res. 2018; 51(7):e7288. SantosEJF HortegalEV SerraHO LagesJS Salgado-FilhoN Dos SantosAM Epoetin alfa resistance in hemodialysis patients with chronic kidney disease: a longitudinal study Braz J Med Biol Res 2018 51 7 e7288 Search in Google Scholar

24 Kaneko S, Hirai K, Morino J, Minato S, Yanai K, Mutsuyoshi Y, Ishii H, Matsuyama M, Kitano T, Shindo M, Aomatsu A, Miyazawa H, Ueda Y, Ito K, Ookawara S, Morishita Y. Association between carnitine deficiency and the erythropoietin resistance index in patients undergoing peritoneal dialysis: a cross-sectional observational study. Ren Fail. 2020 Nov;42(1):146–153. KanekoS HiraiK MorinoJ MinatoS YanaiK MutsuyoshiY IshiiH MatsuyamaM KitanoT ShindoM AomatsuA MiyazawaH UedaY ItoK OokawaraS MorishitaY Association between carnitine deficiency and the erythropoietin resistance index in patients undergoing peritoneal dialysis: a cross-sectional observational study Ren Fail 2020 Nov 42 1 146 153 Search in Google Scholar

25 Wu HHL, Chinnadurai R. Erythropoietin-Stimulating Agent Hyporesponsiveness in Patients Living with Chronic Kidney Disease. Kidney Dis (Basel). 2022 Jan 14; 8(2):103–114. WuHHL ChinnaduraiR Erythropoietin-Stimulating Agent Hyporesponsiveness in Patients Living with Chronic Kidney Disease Kidney Dis (Basel) 2022 Jan 14 8 2 103 114 Search in Google Scholar

26 Radić J, Bašić-Jukić N, Vujičić B, Klarić D, Radulović G, Jakić M, et al. Anemia Is Correlated with Malnutrition and Inflammation in Croatian Peritoneal Dialysis Patients: A Multicenter Nationwide Study. Perit Dial Int. 2017 Jul–Aug;37(4):472–475. RadićJ Bašić-JukićN VujičićB KlarićD RadulovićG JakićM Anemia Is Correlated with Malnutrition and Inflammation in Croatian Peritoneal Dialysis Patients: A Multicenter Nationwide Study Perit Dial Int 2017 Jul–Aug 37 4 472 475 Search in Google Scholar

27 Weir MR. Managing Anemia across the Stages of Kidney Disease in Those Hyporesponsive to Erythropoiesis-Stimulating Agents. Am J Nephrol. 2021; 52(6):450–466. WeirMR Managing Anemia across the Stages of Kidney Disease in Those Hyporesponsive to Erythropoiesis-Stimulating Agents Am J Nephrol 2021 52 6 450 466 Search in Google Scholar

28 Rambod M, Kovesdy CP, Kalantar-Zadeh K. Combined high serum ferritin and low iron saturation in hemodialysis patients: the role of inflammation. Clin J Am Soc Nephrol. 2008 Nov;3(6):1691–1701. RambodM KovesdyCP Kalantar-ZadehK Combined high serum ferritin and low iron saturation in hemodialysis patients: the role of inflammation Clin J Am Soc Nephrol 2008 Nov 3 6 1691 1701 Search in Google Scholar

29 Karaboyas A, Morgenstern H, Fleischer NL, Van-holder RC, Dhalwani NN, Schaeffner E, et al. Inflammation and erythropoiesis-stimulating agent response in hemodialysis patients: a Self-matched Longitudinal Study of anemia management in the dialysis outcomes and Practice Patterns Study (DOPPS). Kidney Med. 2020;2:286–296 KaraboyasA MorgensternH FleischerNL Van-holderRC DhalwaniNN SchaeffnerE Inflammation and erythropoiesis-stimulating agent response in hemodialysis patients: a Self-matched Longitudinal Study of anemia management in the dialysis outcomes and Practice Patterns Study (DOPPS) Kidney Med 2020 2 286 296 Search in Google Scholar

30 Kiss Z, Ambrus C, Kulcsár I, Szegedi J, Kiss I. ACEGENE-BB_HU workgroup; ACEGENE-BB HU workgroup. Effect of angiotensin-converting enzyme gene insertion/deletion polymorphism and angiotensin-converting enzyme inhibition on erythropoiesis in patients on haemodialysis. J Renin Angiotensin Aldosterone Syst. 2015 Dec;16(4):1021–1027. KissZ AmbrusC KulcsárI SzegediJ KissI ACEGENE-BB_HU workgroup ACEGENE-BB HU workgroup Effect of angiotensin-converting enzyme gene insertion/deletion polymorphism and angiotensin-converting enzyme inhibition on erythropoiesis in patients on haemodialysis J Renin Angiotensin Aldosterone Syst 2015 Dec 16 4 1021 1027 Search in Google Scholar

31 Hatano M, Yoshida T, Mimuro T, Kimata N, Tsuchiya K, Sanaka T, Nihei H. The effects of ACE inhibitor treatment and ACE gene polymorphism on erythropoiesis in chronic hemodialysis patients. Nihon Jinzo Gakkai Shi. 2000 Oct; 42(8):632–639. HatanoM YoshidaT MimuroT KimataN TsuchiyaK SanakaT NiheiH The effects of ACE inhibitor treatment and ACE gene polymorphism on erythropoiesis in chronic hemodialysis patients Nihon Jinzo Gakkai Shi 2000 Oct 42 8 632 639 Search in Google Scholar

32 Al-Radeef, M. Y., Fawzi, H. A., & Allawi, A. A. ACE gene polymorphism and its association with serum erythropoietin and hemoglobin ‎in Iraqi hemodialysis patients. The Application of Clinical Genetics. 2019; 12: 107–112. Al-RadeefM. Y. FawziH. A. AllawiA. A. ACE gene polymorphism and its association with serum erythropoietin and hemoglobin ‎in Iraqi hemodialysis patients The Application of Clinical Genetics 2019 12 107 112 Search in Google Scholar